PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsPromethazine
Promethazine
/ Promethazine, Codeine / Phenylephrine / Promethazine, Codeine / Promethazine, Mepergan, Phenylephrine / Promethazine, Promethazine, Promethegan (promethazine) is a small molecule pharmaceutical. Promethazine was first approved as Mepergan on 1982-01-01. It is used to treat allergic conjunctivitis, allergic rhinitis perennial, anaphylaxis, motion sickness, and nausea amongst others in the USA. The pharmaceutical is active against histamine H1 receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
respiratory tract diseasesD012140
otorhinolaryngologic diseasesD010038
eye diseasesD005128
skin and connective tissue diseasesD017437
immune system diseasesD007154
signs and symptoms pathological conditionsD013568
psychological phenomenaD011579
musculoskeletal and neural physiological phenomenaD055687
Trade Name
FDA
EMA
Promethazine, Promethegan (discontinued: Phenergan, Prometh, Prometh fortis, Promethacon, Promethazine, Remsed, Zipan)
Combinations
Phenylephrine promethazine, Prometh hydrochloride,phenylephrine w/codeine, Promethazine, Promethazine codeine, Promethazine dextromethorphan, Promethazine hydrochloride,phenylephrine w/codeine, Promethazine phenylephrine, Promethazine w/ dextromethorphan (discontinued: Mepergan, Phenergan, Phenylephrine promethazine, Pherazine, Prometh, Promethazine, Promethazine codeine, Promethazine dextromethorphan, Promethazine hydrochloride, phenylephrine w/codeine, Promethazine with codeine)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Promethazine hydrochloride
Tradename
Company
Number
Date
Products
PROMETHAZINE HYDROCHLORIDE PLAINANI PharmaceuticalsN-008381 DISCN1982-01-01
2 products, RLD
PHENERGANDelcor AssetN-007935 DISCN1982-01-01
3 products, RLD
PHENERGANMylanN-010926 DISCN1982-01-01
2 products, RLD
PHENERGANMylanN-011689 DISCN1982-01-01
1 products, RLD
PHENERGANWyethN-008857 DISCN1982-01-01
2 products
Hide discontinued
Codeine phosphate
+
Promethazine hydrochloride
Tradename
Company
Number
Date
Products
PHENERGAN W/ CODEINEANI PharmaceuticalsN-008306 DISCN1984-04-02
1 products, RLD
Hide discontinued
Codeine phosphate
+
Phenylephrine hydrochloride
+
Promethazine hydrochloride
Tradename
Company
Number
Date
Products
PHENERGAN VC W/ CODEINEANI PharmaceuticalsN-008306 DISCN1984-04-02
1 products, RLD
Hide discontinued
Phenylephrine hydrochloride
+
Promethazine hydrochloride
Tradename
Company
Number
Date
Products
PHENERGAN VCANI PharmaceuticalsN-008604 DISCN1984-04-02
1 products, RLD
Hide discontinued
Dextromethorphan hydrobromide
+
Promethazine hydrochloride
Tradename
Company
Number
Date
Products
PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDEANI PharmaceuticalsN-011265 RX1984-04-02
1 products, RLD
Meperidine hydrochloride
+
Promethazine hydrochloride
Tradename
Company
Number
Date
Products
MEPERGANHikma PharmaceuticalsN-011730 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
dextromethorphan hydrobromide and promethazine hydrochlorideANDA2024-06-05
phenadozANDA2021-03-01
phenerganANDA2025-06-30
prometh with codeineANDA2012-01-24
promethazineANDA2022-10-08
promethazine and codeineANDA2009-08-21
promethazine and phenylephrine hcl, and codeine phosphateANDA2026-01-08
promethazine dmANDA2025-05-31
promethazine hciANDA2024-02-22
promethazine hclunapproved drug other2014-08-13
Show 15 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
postoperative complications—D011183—
painEFO_0003843D010146R52
vomiting—D014839R11.1
nausea—D009325R11.0
anaphylaxis—D000707T78.2
allergic conjunctivitisEFO_0007141D003233H10.44
allergic rhinitis perennialEFO_1001417D012221J30.89
urticariaEFO_0005531D014581L50
motion sickness—D009041T75.3
cough—D003371R05
Show 8 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D04: Antipruritics, incl. antihistamines, anesthetics, etc.
— D04A: Antipruritics, incl. antihistamines, anesthetics, etc.
— D04AA: Antihistamines for topical use
— D04AA10: Promethazine
R: Respiratory system drugs
— R06: Antihistamines for systemic use
— R06A: Antihistamines for systemic use
— R06AD: Phenothiazine derivatives, systemic antihistamines
— R06AD02: Promethazine
— R06AD52: Promethazine, combinations
V: Various drug classes in atc
— V03: All other therapeutic products
— V03A: All other therapeutic products
— V03AB: Antidotes
— V03AB05: Prednisolone and promethazine
HCPCS
Code
Description
J2180
Injection, meperidine and promethazine hcl, up to 50 mg
J2550
Injection, promethazine hcl, up to 50 mg
Q0169
Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Clinical
Clinical Trials
1214 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypertensionD006973EFO_0000537I10—1612—18
Heart failureD006333EFO_0003144I50——11—2
Graft rejectionD006084—————1—1
DyslipidemiasD050171—————1—1
Insulin resistanceD007333EFO_0002614E88.819———1—1
Myocardial infarctionD009203EFO_0000612I21———1—1
Metabolic syndromeD024821EFO_0000195E88.810———1—1
SyndromeD013577—————1—1
AlbuminuriaD000419EFO_0004285R80.9———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Atrial fibrillationD001281EFO_0000275I48.0——3——3
Colorectal neoplasmsD015179——111——2
Rectal neoplasmsD012004——111——2
CardiomegalyD006332EFO_0002503I51.7—11——1
Myocardial ischemiaD017202EFO_1001375I20-I25——1——1
Cardiovascular diseasesD002318EFO_0000319I98——1——1
Cardiac arrhythmiasD001145EFO_0004269I49.9——1——1
HypercholesterolemiaD006937————1——1
Colonic neoplasmsD003110—C18——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Multiple myelomaD009101—C90.011——13
Plasma cell neoplasmsD054219——11——13
Pancreatic neoplasmsD010190EFO_0003860C25—1———1
Immunoglobulin g4-related diseaseD000077733—D89.84—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Rheumatoid arthritisD001172EFO_0000685M06.93————3
ArthritisD001168EFO_0005856M05-M143————3
Healthy volunteers/patients———3————3
FibrosisD005355——1————1
Drug interactionsD004347——1————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePromethazine
INNpromethazine
Description
Promethazine is a tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety. It has a role as a H1-receptor antagonist, a sedative, an antiemetic, a local anaesthetic, an antipruritic drug, an anti-allergic agent and an anticoronaviral agent. It is a member of phenothiazines and a tertiary amine. It is a conjugate base of a promethazine(1+).
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC(CN1c2ccccc2Sc2ccccc21)N(C)C
Identifiers
PDB—
CAS-ID60-87-7
RxCUI—
ChEMBL IDCHEMBL643
ChEBI ID8461
PubChem CID4927
DrugBankDB01069
UNII IDFF28EJQ494 (ChemIDplus, GSRS)
Target
Agency Approved
HRH1
HRH1
Organism
Homo sapiens
Gene name
HRH1
Gene synonyms
NCBI Gene ID
3269
Protein name
histamine H1 receptor
Protein synonyms
histamine receptor, subclass H1
Uniprot ID
Q6P9E5
Mouse ortholog
Hrh1 (15465)
histamine H1 receptor (Q91XN3)
Alternate
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Promethazine
+
Phenylephrine
+
Codeine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Promethazine
+
Codeine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Promethazine
+
Dextromethorphan
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Promethazine
+
Meperidine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Promethazine
+
Phenylephrine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Promethazine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 7,853 documents
View more details
Safety
Black-box Warning
Black-box warning for: Phenergan, Promethazine and phenylephrine hcl, and codeine phosphate, Promethazine hci, Promethazine hcl, phenylephrine hcl, codeine phosphate, Promethazine hydrochloride and codeine phosphate, Promethazine hydrochloride and dextomethorphan hydrobromide, Promethazine with codeine, Promethazine with codeine cough, Promethazine/codeine, Promethegan
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
17,178 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use